Literature DB >> 10929047

Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London.

A Moody1, A Hunt-Cooke, E Gabbett, P Chiodini.   

Abstract

We report here the sensitivity and specificity of OptiMAL for the diagnosis of acute malaria in patients presenting to the Hospital for Tropical Diseases (HTD), a tertiary referral centre for Tropical and Infectious diseases. A sensitivity of 95.3% and a specificity of 100% for Plasmodium falciparum and a sensitivity of 96% and a specificity of 100% for Plasmodium vivax was obtained. The ability to follow the course of the parasitaemia using OptiMAL during treatment and its significance for use in areas where expert microscopy is not available is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929047     DOI: 10.1046/j.1365-2141.2000.01974.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  36 in total

1.  Poor accuracy of rapid diagnostic tests and misdiagnosis of imported malaria: are PCR-based reference laboratories the answer?

Authors:  Thomas Hänscheid; Emilia Valadas
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Evaluation of the Makromed dipstick assay versus PCR for diagnosis of Plasmodium falciparum malaria in returned travelers.

Authors:  David C Richardson; Michele Ciach; Kathleen J Y Zhong; Ian Crandall; Kevin C Kain
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Comparative diagnostic performance of two commercial rapid tests for malaria in a non-endemic area.

Authors:  F De Monbrison; P Gérome; J F Chaulet; M Wallon; S Picot; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

4.  Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda.

Authors:  François Chappuis; Yolanda Mueller; Alexandre Nguimfack; John Bosco Rwakimari; Sophie Couffignal; Marleen Boelaert; Philippe Cavailler; Louis Loutan; Patrice Piola
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  Evaluation of the ICT malaria P.f/P.v and the OptiMal rapid diagnostic tests for malaria in febrile returned travellers.

Authors:  E Geoffrey Playford; John Walker
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Performance of rapid DiaMed OptiMal-IT(®) malaria test in an endemic Ghanaian setting.

Authors:  P F Ayeh-Kumi; B G Akalifa; N Obeng Nkrumah; R H Asmah; Nicholas T K D Dayie
Journal:  J Parasit Dis       Date:  2011-06-14

7.  Rapid detection of lactate dehydrogenase and genotyping of Plasmodium falciparum in saliva of children with acute uncomplicated malaria.

Authors:  Grace O Gbotosho; Christian T Happi; Onikepe Folarin; Ochuko Keyamo; Akintunde Sowunmi; Ayoade M J Oduola
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

8.  Rapid diagnosis of vivax malaria by the SD Bioline Malaria Antigen test when thrombocytopenia is present.

Authors:  Sei Won Lee; Kyeongman Jeon; Byung Ryul Jeon; Inho Park
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

9.  Production of monoclonal antibodies for Plasmodium vivax lactate dehydrogenase and patient sera screening using sandwich ELISA.

Authors:  Jong-Hyun Kim; Jinyoung Lee; Hae-Jin Sohn; Hyun-Ok Song; Jung-Yeon Kim; Won-Ja Lee; Hyun Park; Ho-Joon Shin
Journal:  Parasitol Res       Date:  2012-06-28       Impact factor: 2.289

10.  Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria.

Authors:  Elizabeth A Ashley; Malek Touabi; Margareta Ahrer; Robert Hutagalung; Khayae Htun; Jennifer Luchavez; Christine Dureza; Stephane Proux; Mara Leimanis; Myo Min Lwin; Alena Koscalova; Eric Comte; Prudence Hamade; Anne-Laure Page; François Nosten; Philippe J Guerin
Journal:  Malar J       Date:  2009-10-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.